Document Detail

Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies.
MedLine Citation:
PMID:  22573127     Owner:  NLM     Status:  Publisher    
OBJECTIVE:: To assess the antihypertensive efficacy of olmesartan medoxomil and ramipril on 24-h ambulatory blood pressure (ABP) in elderly hypertensive patients by pooled data analysis of two studies with identical designs (one Italian, one European). METHODS:: After a 2-week placebo wash-out 1453 elderly hypertensive patients (65-89 years; sitting office DBP 90-109 mmHg and/or sitting office SBP 140-179 mmHg) were randomized to a 12-week double-blind treatment with olmesartan medoxomil 10 mg or ramipril 2.5 mg once-daily, up-titrated (20 and 40 mg olmesartan medoxomil; 5 and 10 mg ramipril) after 2 and 6 weeks in patients without normalized office BP. 24-h ABP was recorded at randomization and after 12 weeks. RESULTS:: In 715 patients with valid baseline and end-of-treatment recordings baseline-adjusted 24-h SBP and DBP reductions were greater with olmesartan medoxomil (n = 356) than with ramipril (n = 359) [between-treatment differences and 95% confidence interval (CI), SBP: 2.2 (3.8, 0.6), P = 0.006; DBP: 1.3 (2.2, 0.3), P = 0.009]. Olmesartan medoxomil showed larger BP reductions in the last 6 h from the dosing interval and higher smoothness indices than ramipril. Olmesartan medoxomil reduced the SBP morning rise [-2.8 (-4.9, -0.8) mmHg], whereas ramipril did not [+1.5 (-0.6, +3.6) mmHg; P = 0.004 between-treatments]. Five hundred and eighty-two patients with sustained hypertension (office and 24-h ambulatory hypertension) showed the largest antihypertensive effect, with between-treatment differences still in favor of olmesartan medoxomil [SBP: 2.1 (3.9, 0.4), P = 0.019; DBP: 1.2 (2.3, 0.1), P = 0.032]. CONCLUSIONS:: Olmesartan medoxomil provides a more effective and sustained 24-h BP control than ramipril in elderly hypertensive patients, particularly in the hours farthest from last intake.
Stefano Omboni; Ettore Malacco; Jean-Michel Mallion; Massimo Volpe; Alberto Zanchetti;
Related Documents :
6093157 - Atenolol-induced regulation of leukocyte beta 2-adrenoceptors in hypertension.
22574537 - Correlation between left atrial volume index and pulmonary artery pressure in patients ...
7420017 - Cardiovascular dynamics and adrenergic responses of the rainbow trout in vivo.
7032747 - Adrenergic responsiveness in prehypertensive subjects.
6469787 - Model analysis of tidal volume response to inspiratory elastic loads.
20058107 - Determination of end point of primary drying in freeze-drying process control.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-8
Journal Detail:
Title:  Journal of hypertension     Volume:  -     ISSN:  1473-5598     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
aItalian Institute of Telemedicine, Varese bDepartment of Internal Medicine. Ospedale L. Sacco, University of Milan, Milan, Italy cCardiology and Arterial Hypertension, CHU de Grenoble, Grenoble, France dDivision of Cardiology, II Faculty of Medicine, University of Rome 'La Sapienza' and IRCCS Neuromed, Pozzilli, Isernia eCentro di Fisiologia Clinica e Ipertensione Università di Milano and Istituto Auxologico Italiano, Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Conversion of IGT to type 2 diabetes mellitus is associated with incident cases of hypertension: a p...
Next Document:  Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general popu...